Creutzfeldt-Jakob disease with unusually extensive neuropathology in a child treated with native human growth hormone

Clinical Neuropathology

Volumn 31, Issue 3, 2012, Pages 127-138

  Mikol, Jacqueline ^a,b   Deslys, Jean Philippe ^c   Zou, Wen Quan ^d   Xiao, Wiangzhu ^d   Brown, Paul ^c   Budka, Herbert ^e   Goutieres, Françoise ^f  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f NONE

Author keywords

Growth hormone treatment; Iatrogenic CJD; Transitional form of panencephalopathic CJD

Indexed keywords

HUMAN GROWTH HORMONE; PRION PROTEIN;

ARTICLE; BRAIN ATROPHY; BRAIN SPONGIOSIS; BRAIN STEM INJURY; CASE REPORT; CEREBELLAR ATAXIA; CEREBELLUM DISEASE; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DETERIORATION; DISEASE COURSE; GENETIC ANALYSIS; GROWTH HORMONE DEFICIENCY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; HYPOPITUITARISM; IATROGENIC CREUTZFELDT JAKOB DISEASE; INTELLIGENCE QUOTIENT; MALE; NERVE DEGENERATION; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; PYRAMIDAL TRACT; SCHOOL CHILD; WESTERN BLOTTING; WHITE MATTER; BRAIN; CREUTZFELDT JAKOB DISEASE; FATALITY; PATHOLOGY;

BRAIN; CHILD; CREUTZFELDT-JAKOB SYNDROME; FATAL OUTCOME; HUMAN GROWTH HORMONE; HUMANS; MALE;

EID: 84863999188     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/NP300441     Document Type: Article

References (38)

1. Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, d'Aignaux JH, Cervenáková L, Fradkin J, Schonberger LB, Collins SJ. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology. 2000; 55: 1075-1081
2. INVS. Maladie de Creutzfeldt-Jakob et formes apparentées. 2010.
3. Deslys JP, Lasmézas C, Dormont D. Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease. Lancet. 1994; 343: 848-849.
4. Yuan J, Xiao X, Qing L, Mikol J, Ironside JW, Gambetti P, Kong Q. WQ Zou. Comparative study of prions associated with iatrogenic and sporadic Creutzfeldt-Jakob disease. Prion. 2009; 3: 73.
5. Mikol J, Goutieres F, Deslys JP, Parchi P. Growth hormone induced Creutzfeldt-Jakob disease (CJD) in a child with extensive lesions. Brain Pathol. 1994; 4: 475
6. Mizutani T, Okumura A, Oda M, Shiraki H. Panencephalopathic type of Creutzfeldt-Jakob disease: primary involvement of the cerebral white matter. J Neurol Neurosurg Psychiatry. 1981; 44: 103-115.
7. Mizutani T. Neuropathology of Creutzfeldt-Jakob disease in Japan. With special reference to the panencephalopathic type. Acta Pathol Jpn. 1981; 31: 903-922
8. Iwasaki Y, Mimuro M, Yoshida M, Hashizume Y, Kitamoto T, Sobue G. Clinicopathologic characteristics of five autopsied cases of dura mater-associated Creutzfeldt-Jakob disease. Neuropathology. 2008; 28: 51-61.
9. Desrues I Maladie de Creutzfeldt-Jakob après traitement par hormone de croissance extractive humaine. Les premières observations françaises. A propos de douze cas. Thesis: Paris VI University; 1992.
10. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999; 46: 224-233.
11. Chrétien F, Le Pavec G, Vallat-Decouvelaere AV, Delisle MB, Uro-Coste E, Ironside JW, Gambetti P, Parchi P, Créminon C, Dormont D, Mikol J, Gray F, Gras G. Expression of excitatory amino acid transporter-1 (EAAT-1) in brain macrophages and microglia of patients with prion diseases. J Neuropathol Exp Neurol. 2004; 63: 1058-1071
12. Yuan J, Xiao X, McGeehan J, Dong Z, Cali I, Fujioka H, Kong Q, Kneale G, Gambetti P, Zou WQ. Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains. J Biol Chem. 2006; 281: 34848-34858.
13. Zou WQ, Langeveld J, Xiao X, Chen S, McGeer PL, Yuan J, Payne MC, Kang HE, McGeehan J, Sy MS, Greenspan NS, Kaplan D, Wang GX, Parchi P, Hoover E, Kneale G, Telling G, Surewicz WK, Kong Q, Guo JP. PrP conformational transitions alter species preference of a PrP-specific antibody. J Biol Chem. 2010; 285: 13874-13884.
14. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AA, Trojanowski JQ, Petersen RB, Gambetti P. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 1996; 39: 767-778.
15. Zou WQ, Capellari S, Parchi P, Sy MS, Gambetti P, Chen SG. Identification of novel proteinase Kresistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem. 2003; 278: 40429-40436.
16. Billette de Villemeur T, Deslys JP, Pradel A, Soubrié C, Alpérovitch A, Tardieu M, Chaussain JL, Hauw JJ, Dormont D, Ruberg M, Agid Y. Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology. 1996; 47: 690-695
17. Collinge J, Palmer MS, Dryden AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet. 1991; 337: 1441-1442.
18. Brandel JP, Preece M, Brown P, Croes E, Laplanche JL, Agid Y, Will R, Alpérovitch A. Distribution of codon 129 genotype in human growth hormonetreated CJD patients in France and the UK. Lancet. 2003; 362: 128-130.
19. IGAS. Rapport sur la maladie de Creutzfeldt-Jakob; 1992.
20. Pocchiari M, Puopolo M, Croes EA, Budka H, Gelpi E, Collins S, Lewis V, Sutcliffe T, Guilivi A, Delasnerie-Laupretre N, Brandel JP, Alperovitch A, Zerr I, Poser S, Kretzschmar HA, Ladogana A, Rietvald I, Mitrova E, Martinez-Martin P, de Pedro-Cuesta J et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain. 2004; 127: 2348-2359.
21. Boesenberg C, Schulz-Schaeffer WJ, Meissner B, Kallenberg K, Bartl M, Heineman U, Krasnianski A, Stoeck K, Varges D, Windl O, Kretzschmar HA, Zerr I. Clinical course in young patients with sporadic Creutzfeldt-Jakob disease. Ann Neurol. 2005; 58: 533-543.
22. Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, Gullotta F, Haltia M, Hauw JJ, Ironside JW, Jellinger K et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalop athies (prion diseases). Brain Pathol. 1995; 5: 459-66.
23. Mikol J. Acquired forms of Creutzfeldt-Jakob disease. Clin Exp Pathol. 1999; 47: 145-51.
24. Iwasaki Y, Yoshida M, Hashizume Y, Kitamoto T, Sobue G. Neuropathologic characteristics of spinal cord lesions in sporadic Creutzfeldt-Jakob disease. Acta Neuropathol. 2005; 110: 490-500.
25. Ghorayeb I, Series C, Parchi P, Sawan B, Guez S, Laplanche JL, Capellari S, Gambetti P, Vital C. Creutzfeldt-Jakob disease with long duration and panencephalopathic lesions: molecular analysis of one case. Neurology. 1998; 51: 271-274.
26. Jansen C, Head MW, Rozemuller AJ, Ironside JW. Panencephalopathic Creutzfeldt-Jakob disease in the Netherlands and the UK: clinical and pathological characteristics of nine patients. Neuropathol Appl Neurobiol. 2009; 35: 272-282.
27. Cruz-Sanchez F, Lafuente J, Gertz HJ, Stoltenburg-Didinger G. Spongiform encephalopathy with extensive involvement of white matter. J Neurol Sci. 1987; 82: 81-87.
28. Macchi G, Abbamondi AL, di Trapani G, Sbriccoli A. On the white matter lesions of the Creutzfeldt-Jakob disease. Can a new subentity be recognized in man? J Neurol Sci. 1984; 63: 197-206.
29. Carota A, Pizzolato GP, Gailloud P, Macchi G, Fasel J, Le Floch J, Cardone F. A panencephalopathic type of Creutzfeldt-Jakob disease with selective lesions of the thalamic nuclei in 2 Swiss patients. Clin Neuropathol. 1996; 15: 125-134.
30. Pascual Lozano A, Salvador-Aliaga A, Coret F, Lainez-Andres J. Atypical clinicoradiological course in a case panancephalic variant of Creutzfeldt-Jakob. Neurologia. 2006; 21: 439-443.
31. Armstrong RA. A quantitative study of the pathological changes in the cortical white matter in variant Creutzfeldt-Jakob disease (vCJD). Clin Neuropathol. 2010; 29: 390-396.
32. Dickson DW, Yen SH, Suzuki KI, Davies P, Garcia JH, Hirano A. Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol. 1986; 71: 216-223.
33. Brion S, Mikol J, Psimaras A. Recent findings in Pick's disease. In: Zimmerman HM (ed). Progress in Neuropathology. New York: Grune and Stratton; 1973. p. 421-452.
34. Palmini A, Najm I, Avanzini G, Babb T, Guerrini R, Foldvary-Schaefer N, Jackson G, Luders HO, Prayson R, Spreafico R, Vinters HV. Terminology and classification of the cortical dysplasias. Neurology. 2004; 62: S2-S8.
35. Thom M, Martinian L, Caboclo LO, McEvoy AW, SM S. Balloon cells associated with granule cells dispersion in the dentate gyrus in hippocampal sclerosis. Acta Neuropathol. 2008; 115: 697-700.
36. Nakazato Y, Hirato J, Ishida Y, Hoshi S, Hasegawa M, Fukuda T. Swollen cortical neurons in Creutzfeldt-Jakob disease contain a phosphorylated neurofilament epitope. J Neuropathol Exp Neurol. 1990; 49: 197-205.
37. Pietrini V, Danieli D, Bevilacqua P, Lechi A. Panencephalopathic type of Creutzfeldt-Jakob disease with neuropathologic features similar to Pick's disease. Clin Neuropathol. 1993; 12: 1-6.
38. Collinge J, Owen F, Poulter M, Leach M, Crow TJ, Rossor MN, Hardy J, Mullan MJ, Janota I, Lantos PL. Prion dementia without characteristic